Molecular mediators of hepatic steatosis and liver injury

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672

Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action

Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652

Nonalcoholic Fatty Liver Disease

Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228

Weight-Reducing Effects of the Plasma Protein Encoded by the obese Gene

Halaas, J. L., Gajiwala, K. S., Maffei, M., Cohen, S. L., Chait, B. T., Rabinowitz, D., Lallone, R. L., Burley, S. K., & Friedman, J. M. (1995) · Science · doi:10.1126/science.7624777 · Cited by 4,451

Steatohepatitis: A tale of two “hits”?

Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285

SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver

Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092

The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor

Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834

Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor

Tontonoz, P., Hu, E., & Spiegelman, B. M. (1994) · Cell · doi:10.1016/0092-8674(94)90006-x · Cited by 3,564

Nonalcoholic Fatty Liver Disease

Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581

Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference

Neuschwander‐Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,166

The significance of differences in fatty acid metabolism between obese and non-obese patients with non-alcoholic fatty liver disease

Enjoji (1998) · International Journal of Molecular Medicine · doi:10.3892/ijmm_00000070 · Cited by 56

Visualization of endoplasmic reticulum viscosity in the liver of mice with nonalcoholic fatty liver disease by a near-infrared fluorescence probe

Zhou, Y., Liu, Z., Qiao, G., Tang, B., & Li, P. (2021) · Chinese Chemical Letters · doi:10.1016/j.cclet.2021.04.035 · Cited by 55

Chronic Ethanol Consumption in Mice Alters Hepatocyte Lipid Droplet Properties

Orlicky, D. J., Roede, J. R., Bales, E. S., Greenwood, C., Greenberg, A. S., Petersen, D. R., & McManaman, J. L. (2011) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2011.01434.x · Cited by 55

Antihyperlipidemic and Antitumor Effects of Chickpea Albumin Hydrolysate

Xue, Z., Gao, J., Zhang, Z., Yu, W., Wang, H., & Kou, X. (2012) · Plant Foods for Human Nutrition · doi:10.1007/s11130-012-0311-3 · Cited by 55

Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo

Wang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 55

Exenatide Delays the Progression of Nonalcoholic Fatty Liver Disease in C57BL/6 Mice, Which May Involve Inhibition of the NLRP3 Inflammasome through the Mitophagy Pathway

Shao, N., Yu, X., Ma, X., Lin, W., Hao, M., & Kuang, H. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/1864307 · Cited by 55

Chronic exposure to low doses of Pb induces hepatotoxicity at the physiological, biochemical, and transcriptomic levels of mice

Luo, T., Shen, M., Zhou, J., Wang, X., Xia, J., Fu, Z., & Jin, Y. (2019) · Environmental Toxicology · doi:10.1002/tox.22706 · Cited by 55

Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice

Yang, C., Zhu, L., Kang, Q., Lee, H. K., Li, D., Chung, A. C. K., & Cai, Z. (2019) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2019.120766 · Cited by 55

mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma

Li, T., Weng, J., Zhang, Y., Liang, K., Fu, G., Li, Y., Bai, X., & Gao, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1828-2 · Cited by 55

Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C

Mitsuyoshi, H., Itoh, Y., Sumida, Y., Minami, M., Yasui, K., Nakashima, T., & Okanoue, T. (2007) · Hepatology Research · doi:10.1111/j.1872-034x.2007.00280.x · Cited by 55

Herbal medicines for fatty liver diseases

Liu, Z., Zhu, J., Wu, Y., Zhuang, X., & Liu, J. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009059 · Cited by 55

Zebrafish facilitate non‐alcoholic fatty liver disease research: Tools, models and applications

Chang, C., Li, H., & Zhang, R. (2023) · Liver International · doi:10.1111/liv.15601 · Cited by 54

Diagnostic Accuracy of CT for the Detection of Hepatic Steatosis: A Systematic Review and Meta-Analysis

Haghshomar, M., Antonacci, D., Smith, A. D., Thaker, S., Miller, F. H., & Borhani, A. A. (2024) · Radiology · doi:10.1148/radiol.241171 · Cited by 54

High fat diet induced insulin resistance and glucose intolerance are gender-specific in IGF-1R heterozygous mice

Garg, N., Thakur, S., McMahan, C. A., & Adamo, M. L. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.08.123 · Cited by 54

Fenugreek seed powder mitigates cadmium-induced testicular damage and hepatotoxicity in male rats

Arafa, M. H., Mohammad, N. S., & Atteia, H. H. (2014) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2014.04.001 · Cited by 54

The roles of ER stress and P450 2E1 in CCl4-induced steatosis

Lee, G., Bhandary, B., Lee, E. M., Park, J., Jeong, K., Kim, I.-K., Kim, H., & Chae, H. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.06.010 · Cited by 54

Lipoic acid administration prevents nonalcoholic steatosis linked to long-term high-fat feeding by modulating mitochondrial function

Valdecantos, M. P., Pérez‐Matute, P., González‐Muniesa, P., Prieto-Hontoria, P. L., Moreno-Aliaga, M. J., & Martínez, J. A. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2011.11.011 · Cited by 54

Fructose-rich diet leads to reduced aerobic capacity and to liver injury in rats

Botezelli, J. D., Cambri, L. T., Ghezzi, A. C., Dalia, R. A., Voltarelli, F. A., & de Mello, M. A. R. (2012) · Lipids in Health and Disease · doi:10.1186/1476-511x-11-78 · Cited by 54

Apolipoprotein A5: Extracellular and Intracellular Roles in Triglyceride Metabolism

Forte, T. M., & Ryan, R. O. (2015) · Current Drug Targets · doi:10.2174/1389450116666150531161138 · Cited by 54

STK25 is a critical determinant in nonalcoholic steatohepatitis

Amrutkar, M., Chursa, U., Kern, M., Nuñez‐Durán, E., Ståhlman, M., Sütt, S., Borén, J., Johansson, B. R., Marschall, H., Blüher, M., et al. (2016) · The FASEB Journal · doi:10.1096/fj.201600562r · Cited by 54

Fas cell surface death receptor controls hepatic lipid metabolism by regulating mitochondrial function

Item, F., Wueest, S., Lemos, V., Stein, S., Lucchini, F. C., Denzler, R., Fisser, M. C., Challa, T. D., Pirinen, E., Kim, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00566-9 · Cited by 54

Akt3 inhibits adipogenesis and protects from diet-induced obesity via WNK1/SGK1 signaling

Ding, L., Zhang, L., Biswas, S., Schugar, R. C., Brown, J. M., Byzova, T. V., & Podrez, E. A. (2017) · JCI Insight · doi:10.1172/jci.insight.95687 · Cited by 54

Alisol A 24-acetate ameliorates nonalcoholic steatohepatitis by inhibiting oxidative stress and stimulating autophagy through the AMPK/mTOR pathway

Wu, C., Jing, M., Yang, L., Lei, J., Ding, Y., Lu, J., Cao, Q., & Jiang, Y. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.06.005 · Cited by 54

Sparing of Methionine Requirements: Evaluation of Human Data Takes Sulfur Amino Acids Beyond Protein

Fukagawa, N. K. (2006) · Journal of Nutrition · doi:10.1093/jn/136.6.1676s · Cited by 54

Iron Overload Causes Oxidative Stress and Impaired Insulin Signaling in AML-12 Hepatocytes

Messner, D. J., Rhieu, B. H., & Kowdley, K. V. (2013) · Digestive Diseases and Sciences · doi:10.1007/s10620-013-2648-3 · Cited by 54

Hepatic ATGL knockdown uncouples glucose intolerance from liver TAG accumulation

Ong, K. T., Mashek, M. T., Bu, S. Y., & Mashek, D. G. (2012) · The FASEB Journal · doi:10.1096/fj.12-213454 · Cited by 53

A Cohort Study of Serum Bilirubin Levels and Incident Non-Alcoholic Fatty Liver Disease in Middle Aged Korean Workers

Chang, Y., Ryu, S., Zhang, Y., Son, H. J., Kim, J., Cho, J., & Güallar, E. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037241 · Cited by 53

A novel cystine based antioxidant attenuates oxidative stress and hepatic steatosis in diet-induced obese mice

Sinha‐Hikim, I., Sinha‐Hikim, A. P., Shen, R., Kim, H., French, S. W., Vaziri, N. D., Crum, A., Rajavashisth, T. B., & Norris, K. C. (2011) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2011.04.009 · Cited by 53

Liver Steatosis in Obese Prepubertal Children: A Possible Role of Insulin Resistance

D’Adamo, E., Impicciatore, M., Capanna, R., Marcovecchio, M. L., Masuccio, F. G., Chiarelli, F., & Mohn, A. (2008) · Obesity · doi:10.1038/oby.2007.122 · Cited by 53

Nonalcoholic fatty liver disease: Diagnosis, pathogenesis, and management

Başaranoğlu, M., & Örmecı, N. (2014) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2014.7675 · Cited by 53

Roles of Fas/Fasl, Bcl-2/Bax, and Caspase-8 in rat nonalcoholic fatty liver disease pathogenesis

Li, C. P., Li, J. H., He, S. Y., Li, P., & Zhong, X. L. (2014) · Genetics and Molecular Research · doi:10.4238/2014.may.23.10 · Cited by 53

Hepatic Metabolism in Liver Health and Disease

Liu, X., Wang, H., Liang, X., & Roberts, M. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804274-8.00030-8 · Cited by 53

Amino acid levels in nascent metabolic syndrome: A contributor to the pro-inflammatory burden

Reddy, P., Leong, J., & Jialal, I. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.02.005 · Cited by 53

Hepatic CREBZF couples insulin to lipogenesis by inhibiting insig activity and contributes to hepatic steatosis in diet‐induced insulin‐resistant mice

Zhang, F., Hu, Z., Li, G., Huo, S., Ma, F., Cui, A., Xue, Y., Han, Y., Gong, Q., Gao, J., et al. (2018) · Hepatology · doi:10.1002/hep.29926 · Cited by 53

Efficacy and Mechanism of Polymerized Anthocyanin from Grape-Skin Extract on High-Fat-Diet-Induced Nonalcoholic Fatty Liver Disease

Fan, M., Choi, Y., Tang, Y., Bae, S. M., Yang, H. P., & Kim, E. (2019) · Nutrients · doi:10.3390/nu11112586 · Cited by 53

Regulation of oxidative stress and inflammation by hepatic adiponectin receptor 2 in an animal model of nonalcoholic steatohepatitis.

Matsunami, T., Sato, Y., Ariga, S., Sato, T., Kashimura, H., Hasegawa, Y., & Yukawa, M. (2010) · PubMed Central · Cited by 53

Biosynthesis and bioavailability of long-chain polyunsaturated fatty acids in non-alcoholic fatty liver disease

Gormaz, J. G., Rodrigo, R., Videla, L. A., & Beems, M. V. (2010) · Progress in Lipid Research · doi:10.1016/j.plipres.2010.05.003 · Cited by 53

Relationship of Liver Enzymes to Insulin Sensitivity and Intra-Abdominal Fat

Wallace, T. M., Utzschneider, K. M., Tong, J., Carr, D. B., Zraika, S., Bankson, D. D., Knopp, R. H., & Kahn, S. E. (2007) · Diabetes Care · doi:10.2337/dc06-1758 · Cited by 53

S-Allyl cysteine attenuates free fatty acid-induced lipogenesis in human HepG2 cells through activation of the AMP-activated protein kinase-dependent pathway

Hwang, Y. P., Kim, H. G., Choi, J. H., Truong, M., Chung, Y., Jeong, T. C., & Jeong, H. G. (2013) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.12.006 · Cited by 53

Subcutaneous vitamin E ameliorates liver injury in an in vivo model of steatocholestasis†‡

Soden, J. S., Devereaux, M. W., Haas, J. E., Gumpricht, E., Dahl, R., Gralla, J., Traber, M. G., & Sokol, R. J. (2007) · Hepatology · doi:10.1002/hep.21690 · Cited by 53

Metabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed

D’Adamo, E., Santoro, N., & Caprio, S. (2011) · Pediatric Clinics of North America · doi:10.1016/j.pcl.2011.07.005 · Cited by 52

Non-alcoholic fatty liver induces insulin resistance and metabolic disorders with development of brain damage and dysfunction

Ghareeb, D. A., Hafez, H. S., Hussien, H. M., & Kabapy, N. F. (2011) · Metabolic Brain Disease · doi:10.1007/s11011-011-9261-y · Cited by 52

Association of Polymorphisms in Glutamate-Cysteine Ligase Catalytic Subunit and Microsomal Triglyceride Transfer Protein Genes with Nonalcoholic Fatty Liver Disease

Hashemi, M. M., Hoseini, H., Yaghmaei, P., Moazeni‐Roodi, A., Bahari, A., Hashemzehi, N., & Shafieipour, S. (2011) · DNA and Cell Biology · doi:10.1089/dna.2010.1162 · Cited by 52

Paediatric non‐alcoholic fatty liver disease: an overview

AlKhater, S. A. (2015) · Obesity Reviews · doi:10.1111/obr.12271 · Cited by 52

Hyperandrogenism and insulin resistance contribute to hepatic steatosis and inflammation in female rat liver

Zhang, Y., Meng, F., Sun, X., Sun, X., Hu, M., Cui, P., Vestin, E., Li, X., Li, W., Wu, X., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24477 · Cited by 52

Dyslipidemia is associated with pediatric nonalcoholic fatty liver disease

Dowla, S. A., Aslibekyan, S. W., Goss, A. M., Fontaine, K. R., & Ashraf, A. P. (2018) · Journal of clinical lipidology · doi:10.1016/j.jacl.2018.03.089 · Cited by 52

Swimming training beneficial effects in a mice model of nonalcoholic fatty liver disease

Schultz, A., Mendonca, L. S., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2010) · Experimental and Toxicologic Pathology · doi:10.1016/j.etp.2010.08.019 · Cited by 52

Reversal of high-fat diet-induced hepatic steatosis by n-3 LCPUFA: Role of PPAR-α and SREBP-1c

Dossi, C. G., Tapia, G. S., Espinosa, A., Videla, L. A., & D'Espessailles, A. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2014.04.011 · Cited by 51

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, and Prevention

Baffy, G. (2013) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2013.00005 · Cited by 51

Independent and Supra-Additive Effects of Alcohol Consumption, Cigarette Smoking, and Metabolic Syndrome on the Elevation of Serum Liver Enzyme Levels

Park, E. Y., Lim, M. K., Oh, J., Cho, H., Bae, M. J., Yun, E. H., Kim, D., & Shin, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063439 · Cited by 51

Xanthohumol ameliorates atherosclerotic plaque formation, hypercholesterolemia, and hepatic steatosis in ApoE‐deficient mice

Doddapattar, P., Radović, B., Patankar, J. V., Obrowsky, S., Jandl, K., Nusshold, C., Kolb, D., Vujić, N., Doshi, L. S., Chandak, P. G., et al. (2013) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200794 · Cited by 51

Mindin/Spondin 2 inhibits hepatic steatosis, insulin resistance, and obesity via interaction with peroxisome proliferator-activated receptor α in mice

Zhu, L., Wang, A., Luo, P., Wang, X., Jiang, D.-S., Deng, W., Zhang, X., Wang, T., Liu, Y., Gao, L., et al. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.01.011 · Cited by 51

Effect of green tea on hepatic lipid metabolism in mice fed a high-fat diet

Nam, M., Choi, M., Choi, J., Kim, N., Kim, M., Jung, S., Kim, J., Ryu, D. H., & Hwang, G. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.09.002 · Cited by 51

Curcumin supplementation mitigates NASH development and progression in female Wistar rats

Cunningham, R. P., Moore, M. P., Moore, A. N., Healy, J. C., Roberts, M. D., Rector, R. S., & Martin, J. S. (2018) · Physiological Reports · doi:10.14814/phy2.13789 · Cited by 51

A systems biology approach to the pathogenesis of obesity-related nonalcoholic fatty liver disease using reverse phase protein microarrays for multiplexed cell signaling analysis

Calvert, V. S., Collantes, R. S., Elariny, H. A., Afendy, A., Baranova, A. V., Mendoza, M. V., Goodman, Z. D., Liotta, L. A., Petricoin, E. F., & Younossi, Z. M. (2007) · Hepatology · doi:10.1002/hep.21688 · Cited by 51

Sleep-Disordered Breathing and Metabolic Effects: Evidence from Animal Models

Jun, J. C., & Polotsky, V. Y. (2007) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.03.009 · Cited by 52

Current innovations in nutraceuticals and functional foods for intervention of non-alcoholic fatty liver disease

Zhao, M., Chen, S., Ji, X., Shen, X., You, J., Liang, X., Yin, H., & Zhao, L. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105517 · Cited by 50

The contribution of sterile inflammation to the fatty liver disease and the potential therapies

Shaker, M. E. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112789 · Cited by 51

Phosphatidylethanolamine N-methyltransferase: from Functions to Diseases

Li, J., Xin, Y., Li, J., Chen, H., & Li, H. (2022) · Aging and Disease · doi:10.14336/ad.2022.1025 · Cited by 50

Pioglitazone retrieves hepatic antioxidant DNA repair in a mice model of high fat diet

Hsiao, P., Hsieh, T., Kuo, K., Hung, W., Tsai, K., Yang, C.-H., Yu, M., & Shin, S. (2008) · BMC Molecular Biology · doi:10.1186/1471-2199-9-82 · Cited by 50

Fine-Mapping Gene-by-Diet Interactions on Chromosome 13 in a LG/J × SM/J Murine Model of Obesity

Ehrich, T. H., Hrbek, T., Kenney‐Hunt, J. P., Pletscher, L. S., Wang, B., Semenkovich, C. F., & Cheverud, J. M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1863 · Cited by 50

Putative Mechanisms of Environmental Chemical–Induced Steatosis

Kaiser, J. P., Lipscomb, J. C., & Wesselkamper, S. C. (2012) · International Journal of Toxicology · doi:10.1177/1091581812466418 · Cited by 50

Concise Review: Current Status and Future Directions on Research Related to Nonalcoholic Fatty Liver Disease

Wruck, W., Graffmann, N., Kawala, M.-A., & Adjaye, J. (2016) · Stem Cells · doi:10.1002/stem.2454 · Cited by 50

Red paprika (Capsicum annuum L.) and its main carotenoid capsanthin ameliorate impaired lipid metabolism in the liver and adipose tissue of high-fat diet-induced obese mice

Kim, J., Ha, T. Y., Kim, S., Lee, S., & Ahn, J. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.01.044 · Cited by 50

Rosuvastatin attenuates piroxicam-mediated gastric ulceration and hepato-renal toxicity in rats

Abdeen, A., Aboubakr, M., Elgazzar, D., Abdo, M., Abdelkader, A., Ibrahim, S., & Elkomy, A. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.11.004 · Cited by 50

Targeted Delivery of Stk25 Antisense Oligonucleotides to Hepatocytes Protects Mice Against Nonalcoholic Fatty Liver Disease

Cansby, E., Nuñez‐Durán, E., Magnusson, E., Amrutkar, M., Booten, S. L., Kulkarni, N. M., Svensson, T., Borén, J., Marschall, H., Aghajan, M., et al. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2018.12.004 · Cited by 50

Dual roles of ULK1 (unc-51 like autophagy activating kinase 1) in cytoprotection against lipotoxicity

Park, J. S., Lee, D. H., Lee, Y. S., Oh, E., Bae, K., Oh, K., Kim, H.-M., & Bae, S. H. (2019) · Autophagy · doi:10.1080/15548627.2019.1598751 · Cited by 51

Progressive Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

Ramai, D., Facciorusso, A., Vigandt, E., Schaf, B., Saadedeen, W., Chauhan, A., di Nunzio, S., Shah, A., Giacomelli, L., & Sacco, R. (2021) · Cells · doi:10.3390/cells10123401 · Cited by 50

Hepatoprotective effect of oleuropein in mice: Mechanisms uncovered by gene expression profiling

Kim, Y., Choi, Y., & Park, T. (2010) · Biotechnology Journal · doi:10.1002/biot.201000068 · Cited by 50

Regulatory effects of arachidonate 5-lipoxygenase on hepatic microsomal TG transfer protein activity and VLDL-triglyceride and apoB secretion in obese mice

López‐Parra, M., Titos, E., Horrillo, R., Ferré, N., González‐Périz, A., Martínez‐Clemente, M., Planagumà, A., Masferrer, J. L., Arroyo, V., & Clària, J. (2008) · Journal of Lipid Research · doi:10.1194/jlr.m800101-jlr200 · Cited by 50

A Computational Model of Hepatic Energy Metabolism: Understanding Zonated Damage and Steatosis in NAFLD

Ashworth, W. B., Davies, N. A., & Bogle, I. D. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005105 · Cited by 50

Evaluation of the Cholesterol-Lowering Mechanism of Enterococcus faecium Strain 132 and Lactobacillus paracasei Strain 201 in Hypercholesterolemia Rats

Yang, L., Xie, X., Li, Y., Wu, L., Fan, C., Liang, T., Xi, Y., Yang, S., Li, H., Zhang, J., et al. (2021) · Nutrients · doi:10.3390/nu13061982 · Cited by 49

Hepatitis C Virus-Induced Steatosis: An Overview

Negro, F. (2010) · Digestive Diseases · doi:10.1159/000282105 · Cited by 49

Desmosterol in Human Nonalcoholic Steatohepatitis

Simonen, M., Männistö, V., Leppänen, J., Kamińska, D., Kärjä, V. J., Venesmaa, S., Käkelä, P., Kuusisto, J., Gylling, H., Laakso, M., et al. (2013) · Hepatology · doi:10.1002/hep.26342 · Cited by 49

Antisense oligonucleotide reduction of apoB-ameliorated atherosclerosis in LDL receptor-deficient mice

Mullick, A. E., Fu, W., Graham, M. J., Lee, R. G., Witchell, D. R., Bell, T. A., Whipple, C. P., & Crooke, R. M. (2011) · Journal of Lipid Research · doi:10.1194/jlr.m011791 · Cited by 49

Mice deficient in Group VIB phospholipase A2(iPLA2γ) exhibit relative resistance to obesity and metabolic abnormalities induced by a Western diet

Song, H., Wohltmann, M., Bao, S. S., Ladenson, J. H., Semenkovich, C. F., & TURK, J. W. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00780.2009 · Cited by 49

Binge Alcohol Consumption Aggravates Oxidative Stress and Promotes Pathogenesis of NASH from Obesity-Induced Simple Steatosis

Minato, T., Tsutsumi, M., Tsuchishima, M., Hayashi, N., Saito, T., Matsue, Y., Toshikuni, N., Arisawa, T., & George, J. (2014) · Molecular Medicine · doi:10.2119/molmed.2014.00048 · Cited by 49

Targeting hepatic pyruvate dehydrogenase kinases restores insulin signaling and mitigates ChREBP-mediated lipogenesis in diet-induced obese mice

Wu, C., Tso, S.-C., Chuang, J. L., Gui, W. J., Lou, M., Sharma, G., Khemtong, C., Qi, X., Wynn, R., & Chuang, D. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.03.014 · Cited by 49

The Influence of Different Fat Sources on Steatohepatitis and Fibrosis Development in the Western Diet Mouse Model of Non-alcoholic Steatohepatitis (NASH)

Drescher, H. K., Weiskirchen, R., Fülöp, A., Hopf, C., Román, E. G. D. S., Huesgen, P. F., de Bruin, A., Bongiovanni, L., Christ, A., Tolba, R. H., et al. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00770 · Cited by 49

Omega-3 Polyunsaturated Fatty Acids Prevent Nonalcoholic Steatohepatitis (NASH) and Stimulate Adipogenesis

Antraco, V. J., Hirata, B. K. S., Simão, J. D. J., Cruz, M. M., da Silva, V. S., de Sá, R. D. C. D. C., Abdala, F. M., Armelin‐Correa, L., & Alonso‐Vale, M. I. C. (2021) · Nutrients · doi:10.3390/nu13020622 · Cited by 49

The genetic interactions between non-alcoholic fatty liver disease and cardiovascular diseases

Chew, N., Chong, B., Ng, C. H., Kong, G., Chin, Y. H., Xiao, W., Lee, C. J. M., Dan, Y. Y., Muthiah, M. D., & Foo, R. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.971484 · Cited by 49

Effect of a hypocaloric diet in transaminases in nonalcoholic fatty liver disease and obese patients, relation with insulin resistance

de Luis, D. A., Aller, R., Izaola, O., Sagrado, M. G., Conde, R., & González, J. M. D. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.07.015 · Cited by 49

Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?

Machado, M. V., & Cortez‐Pinto, H. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.16 · Cited by 49

New insights in the pathogenesis of non-alcoholic fatty liver disease

Gaemers, I. C., & Groen, A. K. (2006) · Current Opinion in Lipidology · doi:10.1097/01.mol.0000226118.43178.98 · Cited by 49

Genetic Variation in the Peroxisome Proliferator Activated Receptor-Gamma Gene Is Associated with Histologically Advanced NAFLD

Gawrieh, S., Marion, M. C., KOMOROWSKI, R. A., Wallace, J. R., Charlton, M., Kissebah, A. H., Langefeld, C. D., & Olivier, M. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1994-2 · Cited by 48

Metabolic Syndrome in Pediatrics: Old Concepts Revised, New Concepts Discussed

D’Adamo, E., Santoro, N., & Caprio, S. (2009) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2009.06.002 · Cited by 48

Inhibitory Effect of Gardenoside on Free Fatty Acid-Induced Steatosis in HepG2 Hepatocytes

Liang, H., Zhang, L., Wang, H., Tang, J., Yang, J., Chuncheng, W., & Chen, S. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161126058 · Cited by 48

Prenatal hyperandrogenism induces alterations that affect liver lipid metabolism

Abruzzese, G. A., Heber, M. F., Ferreira, S. R., Vélez, L. M., Reynoso, R., Pignataro, O. P., & Motta, A. B. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0471 · Cited by 48

Cideb controls sterol‐regulated ER export of SREBP/SCAP by promoting cargo loading at ER exit sites

Su, L., Zhou, L., Chen, F., Wang, H., Qian, H., Sheng, Y., Zhu, Y., Yu, H. J., Gong, X., Cai, L., et al. (2019) · The EMBO Journal · doi:10.15252/embj.2018100156 · Cited by 48

PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats

Zhang, Y., Cui, Y., Wang, X., Shang, X., Qi, Z.-G., Xue, J., Zhao, X., Deng, M., & Xie, M.-L. (2015) · Cytokine · doi:10.1016/j.cyto.2015.05.031 · Cited by 48

Soy Protein Isolate Reduces Hepatosteatosis in Yellow A vy /a Mice Without Altering Coat Color Phenotype

Badger, T. M., Ronis, M. J. J., Wolff, G. L., Stanley, S., Ferguson, M. E., Shankar, K., Simpson, P., & Jo, C.-H. (2008) · Experimental Biology and Medicine · doi:10.3181/0802-rm-60 · Cited by 48

Fasting-Induced Hepatic Production of DHEA Is Regulated by PGC-1α, ERRα, and HNF4α

Grasfeder, L. L., Gaillard, S. L., Hammes, S. R., Ilkayeva, O., Newgard, C. B., Hochberg, R. B., Dwyer, M. A., Chang, C., & McDonnell, D. P. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0024 · Cited by 48

Metformin prevents aggressive ovarian cancer growth driven by high-energy diet: similarity with calorie restriction

Al-Wahab, Z. R., Mert, İ., Tebbe, C., Chhina, J., Hijaz, M., Morris, R. T., Ali‐Fehmi, R., Giri, S., Munkarah, A. R., & Rattan, R. (2015) · Oncotarget · doi:10.18632/oncotarget.3434 · Cited by 47

Thyroid hormone analogues and derivatives: Actions in fatty liver

Coppola, M. (2014) · World Journal of Hepatology · doi:10.4254/wjh.v6.i3.114 · Cited by 47

Effect of ration size on fillet fatty acid composition, phospholipid allostasis and mRNA expression patterns of lipid regulatory genes in gilthead sea bream (Sparus aurata)

Benedito‐Palos, L., Calduch-Giner, J. À., Ballester-Lozano, G. F., & Pérez‐Sánchez, J. (2012) · British Journal Of Nutrition · doi:10.1017/s000711451200311x · Cited by 47

Present and future therapeutic strategies in non-alcoholic fatty liver disease

Calamita, G., & Portincasa, P. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.9.1231 · Cited by 47

Challenges to Glycemic Measurement in the Perioperative and Critically Ill Patient: A Review

Pitkin, A. D., & Rice, M. J. (2009) · Journal of Diabetes Science and Technology · doi:10.1177/193229680900300606 · Cited by 47

Association between nocturnal hypoxia and liver injury in the setting of nonalcoholic fatty liver disease

Lin, Q., Chen, L., Chen, G., Zhao, J., Chen, X., Huang, J., & Wu, L. (2014) · Sleep And Breathing · doi:10.1007/s11325-014-1008-7 · Cited by 47

Constitutive androstane receptor agonist, TCPOBOP, attenuates steatohepatitis in the methionine choline-deficient diet-fed mouse

Baskin-Bey, E. S. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i42.5635 · Cited by 47

Hepatitis B virus induces expression of cholesterol metabolism-related genes via TLR2 in HepG2 cells

Li, Y.-J. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i14.2262 · Cited by 47

A liver-targeted acetyl CoA carboxylase inhibitor reduces hepatic steatosis and liver injury in a murine model of NASH

Bates, J. G., Brockett, R., Mikaelian, I., Wang, T., Ray, A. S., Tumas, D. B., & Breckenridge, D. G. (2017) · Journal of Hepatology · doi:10.1016/s0168-8278(17)31226-6 · Cited by 1

Selective Acetyl-CoA Carboxylase 1 Inhibitor Improves Hepatic Steatosis and Hepatic Fibrosis in a Preclinical Nonalcoholic Steatohepatitis Model

Tamura, Y. O., Sugama, J., Iwasaki, S., Sasaki, M., Yasuno, H., Aoyama, K., Watanabe, M., Erion, D. M., & Yashiro, H. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000786 · Cited by 27

NF- B/HDAC1/SREBP1c pathway mediates the inflammation signal in progression of hepatic steatosis

Guo, Y., Zhang, X., Zhao, Z., Lu, H., Ke, B., Ye, X., Wu, B., & Ye, J. (2020) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2020.02.005 · Cited by 45

The role of AMPKα2 in the HFD-induced nonalcoholic steatohepatitis

Zhang, X., Liu, S., Zhang, C., Zhang, S., Yue, Y., Zhang, Y., Chen, L., Yao, Z., & Niu, W. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165854 · Cited by 17

The SCAP/SREBP Pathway: A Mediator of Hepatic Steatosis

Moon, Y.-A. (2017) · Endocrinology and Metabolism · doi:10.3803/enm.2017.32.1.6 · Cited by 123